Personal injury lawyers at Messa & Associates, P.C. have recently come across news stating that Globus Medical Inc., a spinal implant manufacturer, will pay the U.S. Food and Drug Administration $1 million in penalties for selling its NuBone Osteoinductive Bone Graft product after the FDA rejected the device in 2009.
The FDA learned that Globus was distributing the NuBone Osteoinductive, despite being told that the medical device was not substantially equivalent (NSE) to legally-marketed products, during a September 2010 inspection. The company also ignored multiple warnings given by the FDA to stop selling the device, according to a commissioner for regulatory affairs.
The settlement requires Globus Medical to pay a $550,000 penalty fee and the company’s CEO, David Paul, to pay an additional $450,000 fine.
Personal Injury Lawyers: FDA Approval Process Required NuBone Osteoinductive Devices to Be Substantially Equivalent
The FDA currently uses two procedures to approve medical devices. Clinical trials are necessary to get approval for more critical devices. However, Globus Medical’s NuBone Osteoinductive is considered a medical device that poses a lower level of risk to patients. Therefore, Globus Medical was only required to show that the NuBone Osteoinductive was substantially equivalent to similar medical devices that are already on the market.
Personal Injury Lawyers in Philadelphia and New Jersey
The Philadelphia personal injury lawyers at Messa & Associates are experienced at handling cases involving pharmaceutical and medical device injuries. Our extremely skilled team of personal injury lawyers and medical experts is dedicated to ensuring you receive proper compensation for your personal injuries. If you have been injured by a defective medical device, a negligent medical provider, or have endured any other type of personal injury, contact the personal injury lawyers of Messa & Associates for a free consultation. Call toll free at 1-877-MessaLaw, or submit a free online inquiry.
For immediate assistance, click the CHAT LIVE button to your right.
Traditionally, root canals are performed using small steel posts. Dr. Clair’s scheme to use paper clips instead of surgically competent steel posts caused many patients unnecessary pain, suffering, and infection. Brenda Almeida’s young son underwent the procedure in 2005. His tooth turned black and had to be pulled. Almeida also claims that her other children received poor care from Dr. Clair as well.
Dr. Paul Heltzer and the Staten Island University Hospital were found responsible for the speech probelms, learning disabilities, and reduced life expectancy that Xzavier now faces due to the extended period of time he went without oxygen on the day of his birth.
The Columbia Medical Center of McKinney (MCM) in McKinney, Texas is being sued by
Birth Injuries that commonly occur include Cerebral Palsy, Erb’s Palsy, face paralysis, bruises and swelling, Shoulder Dystocia, and brain damage. These injuries are generally brought on by oxygen deprivation and doctor error. Oxygen deprivation is commonly caused by umbilical cord compression, the improper insertion of an oxygen tube, Meconium Aspiration Syndrome (the baby inahles it’s own fecal matter or amniotic fluid), or excessive time spent in the birth canal.
Martin Chieng Were, M.D., M.S., a Regenstrief Institute investigator and assistant professor of medicine at the Indiana University School of Medicine, has received a $420,000 award from the Harold Amos Medical Faculty Development Program of the
A key issue in the tort reform debate involves “defensive medicine.” Supporters of
Today, we are reporting on the Stratford Nursing & Convalescent Center located in Stratford, New Jersey. The latest published report shows all of the violations found during the routine inspections for the two year period between November 2008 and October 2010. The Stratford Nursing & Convalescent Center had 33 cited nursing home violations on the two combined inspection dates. The facility’s citations included safety code violations, life safety code standard violations, and others related to abuse and neglect. The level of violations were mainly rated as being pattern or widespread violations, with at least four considered to cause immediate jeopardy to the residents health or safety. Stratford’s ratings are a sure cause for concern, and it is quite clear that immediate corrective action needs to be taken. The facility’s noncompliance with one or more standards has caused, or is likely to cause, serious injury, harm, impairment, or death to a patient or resident.
This
DePuy Orthopaedics, a subsidiary of Johnson & Johnson, marketed its DePuy ASR XL Acetabular Hip Imlplant System and ASR Hip Resurfacing Systems worldwide, and all are included in the recall. In December of 2010, about 1,500 Canadian patients who had DePuy hip replacements filed a DePuy class action lawsuit in the courts in Quebec, Calgary, Alberta, Halifax, Nova Scotia, and Montreal. DePuy hip recall lawyers in Canada are helping these DePuy hip recall claimaints. It is likely that other DePuy hip implant patients in Europe will soon be filing similar class actions as a result of the DePuy hip recall.